Latest Manufacturing Expansion News

Page 2 of 11
Orthocell posts record FY26 revenue growth driven by expanding US and international sales of its collagen medical devices, while investing ahead in manufacturing capacity and product pipeline.
Ada Torres
Ada Torres
31 Aug 2026
Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.
Victor Sage
Victor Sage
28 Aug 2026
SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.
Ada Torres
Ada Torres
28 Aug 2026
PolyNovo reported a 16.1% rise in FY26 revenue to AUD 150 million, driven by strong global sales and manufacturing expansion, yet net profit fell 44% due to a significant asset write-off from an R&D centre fire and lower tax benefits.
Ada Torres
Ada Torres
26 Aug 2026
DXN Limited has landed a A$12.2 million contract to deliver a 2MW AI High-Performance Computing modular data centre, expanding its AI HPC order book to about A$21 million and positioning the company for further growth in a booming market.
Sophie Babbage
Sophie Babbage
24 Aug 2026
Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.
Ada Torres
Ada Torres
20 Aug 2026
Adrad Holdings delivered a 15% rise in net profit after tax for FY26, driven by operational efficiency and growth in engineered heat transfer solutions, alongside a 15% dividend increase.
Victor Sage
Victor Sage
18 Aug 2026
CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.
Ada Torres
Ada Torres
18 Aug 2026
Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.
Ada Torres
Ada Torres
31 July 2026
Boresight Ltd (ASX: BST) marked its ASX debut in June with a successful $8 million IPO, reporting a 55% revenue increase in FY26 and securing a major US manufacturing expansion to meet rising defence drone demand.
Victor Sage
Victor Sage
31 July 2026
HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.
Victor Sage
Victor Sage
30 July 2026
The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.
Victor Sage
Victor Sage
30 July 2026

Browse the archive

Full archive